Estratto
In piena era antibiotica, la tubercolosi (Tb) è ancora una delle malattie infettive più diffuse nel mondo, tanto che l’Organizzazione Mondiale della Sanità parla di un terzo della popolazione mondiale infetta con 9 milioni di nuovi casi di malattia per anno e circa 3 milioni di morti. Sono questi i dati relativi ai primi anni del nuovo secolo, per una patologia antica, già presente vari millenni prima di Cristo.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Letture consigliate
American Thoracic Society (2000) Diagnostic Standards and Classification of Tuberculosis in Adults and Children. Am J Respir Crit Care Med 161:1376–1395
Bloom BR (2002) Tuberculosis — the global view. N Engl J Med 346:1434–1435
British Thoracic Association (1982) A controlled trial of six months chemotherapy in pulonary tuberculosis. Second report: results during the 24 months after the end of chemotherapy. Am Rev Respir Dis 126:460–462
British Thoracic Society Research Committee (1992) Six-months versus nine-months chemotherapy for tuberculosis of lymphonodes: preliminary results. Respir Med 86:15–19
Broeckmans JF, Migliori GB, Rieder HL et al (2002) European Framework for Tuberculosis Control and Elimination in Countries with a Low Incidence. Eur Respir J 19:765–775
Campbell IA (1990) The traetment of superficial tubercular lymphadenitis. Tubercle 71:1–3
Carl P, Stark L (1997) Indications for surgical management of genitourinary tuberculosis. World Surg 21:505–510
Cascina A, Peona V (2001) Tubercolosi. In Casali L (ed) Manuale di Malattie dell’apparato respiratorio. Masson, Milano, pp 173–193
Cassone A (2001) Tubercolosi. Epidemiologia, diagnosi e terapia. I manuali. Forum Service Edizioni, Genova
CDC (1996) Nucleic acid amplification tests for Tuberculosis. MMWR 45:950–952
Centers for Diseases Control and Prevention (2000) Update: Nucleic Amplification Tests for Tuberculosis. MMWR 49:593–594
Chan ED, Iseman MD (2002) Current Medical Treatment for Tuberculosis. BMJ 325:1282–1286
Cicchitto G, Parravicini M, De Lorenzo S et al (2001) La tubercolosi multifarmacoresistente. Rassegna di Patologia dell’Apparato Respiratorio 16:104–114
Cole ST, Brosch R, Parkhill J et al (1998) Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 393:537–544
Collins DM (2000) New tuberculosis vaccines based on attenuated strains of the Mycobacterium tuberculosis Complex. Immunol Cell Biol 78:342–345
Crofton J, Horne N, Miller F (1997) Diagnosi e Terapia della tubercolosi. Pacini Editore, Pisa
Davidson PT (1995) Managing tuberculosis during pregnancy. Lancet 346:199–200
Espinal MA, Lazslo A, Simonsen L et al (2001) Global trends in resistance to antituberculosis drugs. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance. N Engl J Med 344:1294–1303
Farmer P (2001) DOTS and DOTS-plus: not the only answer. Ann N Y Acad Sci 953:165–184
Gillespie SH, Kennedy N (1998) Fluoroquinoles: a new treatment for tuberculosis? Int J Tuberc Lung Dis 2:265–271
Gioia C, Agrati C, Goletti D et al (2003) Different Cytokine production and effector/memory Dynamics of alpha beta+ or gamma delta+ T-cells subsets in the peripheral blood of patients with active pulmonary tuberculosis. Int J Immunopathol Pharmacol 16:247–252
Giosuè S, Casarini M, Ameglio F et al (2000) Aerosolized interferon-alfa treatment in patients with multi-drug-resistant pulmonary tuberculosis. Eur Cytokine Netw l:99–103
Good RC, Shinnick TM (1998) Mycobacterium. In Collier L, Balows A, Sussman M (eds) Topley & Wilson’s Microbiology and Microbial Infections, Systematic Bacteriology, vol 2. Arnold, London, pp 549–576
Hale YM, Pfyffer GE, Salfinger M (2001) Laboratory diagnosis of mycobacterial infections: New tools and lessons learned Clin Infect Dis 33:834–846
Hopewell PC (1995) A Clinical View of Tuberculosis. Radiol Clin North Am 33:707–718
Hopewell PC, Bloom BR (2004) Tuberculosis and Other Mycobacterial Diseases. In Murray JF, Nadel JA (eds) Textbook of Respiratory Medicine. WB Saunders, Philadelphia, pp 1043–1105
Horsburgh C Jr, Feldman S, Ridzon R (2000) Practice Guidelines for the Treatment of Tuberculosis. Clin Infect Dis 31:633–639
Jasmer RM, Nahid P, Hopewell PC (2002) Latent Tuberculosis Infection. N Engl J Med 347:1860–1866
Jasmer RM, Snyder DC, Saukkonen JJ et al (2004) Short-Course Rifampin and Pyrazinamide with Isoniazid for Latent Tuberculosis Infection: A Cost-Effectiveness Analysis Based on a Multicenter Clinical Trial. Clin Infect dis 38:363–369
Joint Statement of The American Thoracic Society (ATS) and The Centers for Diseases Control and Prevention (CDC) (2000) Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection. Am J Crit Care Med 161:S221–S247
Lalvani A, Pathan AA, McShane H et al (2001) Rapid detection of Mycobacterium tuberculosis infection by enumeration of antigen specific T-cells. Am J Respir Crit Care Med 163:824–828
Leung AN (1999) Pulmonary Tuberculosis: The Essentials. Radiology 210:307–322
Light RW (1995) Pleural Diseases (3rd ed). Lea & Febiger, Philadelphia
Loddenkemper R (2000) The need of antituberculosis drug surveillance in Europe. Eur Respir J 16:195–196
Mandler F, Passerini Tosi C, Scarparo C et al (1999) Proposta di Linee-guida per la diagnosi microbiologica della tubercolosi. Microbiologica Medica 14:313–330
Massei V (2000) Inquadramento nosografico e forme cliniche della tubercolosi polmonare. In Donner CF, Sanguinetti CM (eds) Trattato Italiano di Pneumologia. EDI-AIPO Scientifica, Pisa, pp 969–988
Mazurek GH, Villarino ME (2003) Guidelines for using the QuantiFERON-TB test for diagnosis latent Mycobacterium Tuberculosis infection. Centers for Disease Control and Prevention. MMWR Recomm Rep 52:15–18
Migliori GB, Ambrosetti M, Besozzi G et al (2000) Microbiological confirmation of tuberculosis cases at diagnosis and the end of treatment in Italy. Eur J Epidemiol 16:719–724
Migliori GB, Ambrosetti M, Fattorini L et al (2000) Surveillance of anti-tuberculosis drug resistance: results of the 1998/1999 proficiency testing in Italy. SMIRA (Italian Multicentre Study on Antituberculosis Drug Resistence) Study Group. Int J Tuberc Lung Dis 4:940–946
Ministero della Sanità (1995) Circolare n. 8, 13 aprile 1995 n. 500. 7/TBC/1368
Ministero della Sanità (1999) Documento di linee guida per il controllo della malattia tubercolare. Gazzetta Ufficiale S.O. n. 40 del 18 febbraio 1999
Mitchinson DA (2000) Role of individual drugs in the chemoterapy of tuberculosis. Int J Tuberc Lung Dis 4:796–806
Muller NL (1993) Images of the pleura. Radiology 186:297–303
Murray JF (2004) A century of tuberculosis. Am J Resp Crit Care Med 169:1181–1186
Nardini S, Bazzerla G, Besozzi G et al (1998) Linee Guida per la gestione del paziente affetto da tubercolosi polmonare. Rassegna di Patologia dell’Apparato Respiratorio 13:244–258
Nutini S, Pasi A, Altieri AM et al (1994) Proposta operativa per la diagnosi, terapia e follow-up del paziente tubercolare. Rassegna di Patologia dell’Apparato Respiratorio 9:49–52
O’Brien RJ, Nunn PP (2001) The need for new drugs against tuberculosis: obstacle, opportunities, and next steps. Am J Respir Crit Care Med 163:1055–1058
Ormerod LP (1996) Hepatotoxicity of antituberculosis drugs. Thorax 51:111–113
Pape JW, Jean SS, Ho JL et al (1993) Effect of isoniazid prophylaxis on incidence of active tuberculosis and progression of HIV infection. Lancet 342:268–272
Pertuiset E, Beaudreuil J, Liote F et al (1999) Spinal tuberculosis in adults. A study of 103 case in a developed country. Medicine 78:309–320
Pomerantz BJ, Cleveland JC Jr, Olson HK, Pomerantz M (2001) Pulmonary resection for multidrug resistant tuberculosis. J Thorac Cardiovasc Surg 121:448–453
Post DJM, Sze G, Quencer RM et al (1990) Gadolinium enhanced MR in spinal infection. J Comput Assist Tomogr 145:721–729
Reichman LB, Hershfield ES (1995) Tuberculosis. A Comprehensive International Approach. Marcel Dekker Inc, New York, Basel, Hong Kong
Rieder H Snider DE Jr, Cauthen GM (1990) Extrapulmonary tuberculosis in the United States. Am Rev Respir Dis 141:347–351
Rieder HL, Zellweger JP, Raviglione MC et al (1994) Tuberculosis control in Europe and international Migration. Eur Respir J 7:1545–1553
Rom W, Harkin T (2003) Linezolid: a promising new agent for multi-drug resistant tuberculosis treatment. 99th International Conference of the American Thoracic Society in Seattle, Abstract P621
Sahn SA, Iseman MD (1999) Tuberculous empyema. Semin Respir Infect 14:82–87
Saunders BM, Cooper AM (2000) Restraining mycobacteria: role of granulomas in mycobacterial infections. Immunol Cell Biol 78:334–37
Schwoebel V, Lambregts-van Weezenbeek CS, Moro ML et al (2000) Standardization of antituberculosis drug resistance surveillance in Europe. Recommendations of a World Health Organization (WHO) and International Union Against Tuberculosis and Lung Disease (IUATLD) Working Group. Eur Respir J 16:364–371
Sepkowitz KA (1996) How contagious is tuberculosis? Clin Infect Dis 23:954–962
Shinnick TM, King CH, Quinn FD (1995) Molecular biology, virulence and pathogenicity of mycobacteria. Am J Med Sci 309:92–98
Staaz G, Adam G, Keulers P et al (1998) Spondylodiskitis abscesses: CT guided percutaneous catheter drainage. Radiology 208:363–367
Tam CM, Chan SL, Kam KM et al (2002) Rifapentine and isoniazid in the continuation phase of treating pulmonary tuberculosis final report. Int J Tuberc Lung Dis 6:63–70
Tsugujuchi I (1996) Regulation of the human immune response in tuberculosis. Infect Ag Diseases 5:171–175
Ulrichs T, Kaufmann SHE (2003) Immunolgy and Persistence. In Kaufmann SHE, Hahn H (eds) Mycobacteria and TB. Karger, Basel, pp 112–127
WHO (1995) Immunization Policy. Global Programme for Vaccines and Immunization. WHO/EPI/GEN/95.03 REV. 1 Geneva
WHO/ IUATLD (2000) Anti-Tuberculosis drug resistance in the world. Report N. 2 WHO/CDS/TB/2000 278, Geneva
WHO (1993) Treatment of Tuberculosis. Guidelines for National Programmes. Geneva
WHO (1994) WHO Programme: Framework for Effective Tuberculosis Control. WHO/TB/94.179:1–13, Geneva
WHO (2000) Global Tuberculosis Control. WHO/CDS/TB/2000. 275, Geneva
WHO (2003) Global Tuberculosis Control: Surveillance, Planning. Financing. WHO/CDS/TB/2003.316, Geneva
Wilson R (1997) Tuberculosis. European Respiratory Monograph, Sheffield
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer-Verlag Italia
About this chapter
Cite this chapter
Alma, M.G., Altieri, A.M. (2006). Tubercolosi polmonare. In: Malattie dell’apparato respiratorio. Springer, Milano. https://doi.org/10.1007/978-88-470-0467-2_22
Download citation
DOI: https://doi.org/10.1007/978-88-470-0467-2_22
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-0466-5
Online ISBN: 978-88-470-0467-2
eBook Packages: MedicineMedicine (R0)